Primary care doctors can accurately detect Alzheimer's with a blood test, showing potential for large impacts and easier patient access.
New drugs for Alzheimer's require early detection, making blood tests crucial over costly and limited options like PET scans and spinal taps.
A study showcased a blood test by C2N Diagnostics matching an FDA-approved spinal fluid test for Alzheimer's molecular signs.
Collection
[
|
...
]